All lobbying filings

HIV AND HEPATITIS POLICY INSTITUTE

Lobbying for HIV AND HEPATITIS POLICY INSTITUTE · Patient advocacy

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $40,000.00 expenses · posted Apr 18, 2026

Official filing document

Bills named in this filing 1

HR 7853
PrEP Access and Coverage Act of 2026

Lobbying activity 6

Insurance

Preventive Service insurance coverage for PrEP, (PrEP Access and Coverage Act (S 3990, HR 7853) Copay Assistance & Cost sharing for prescription drugs, Essential Health Benefits & Prescription Drugs

Pharmacy

Preventive Service coverage for PrEP, PrEP Access and Coverage Act of 2026 (S 3990, HR 7853) Copay Assistance & Cost sharing for prescription drugs; Essential Health Benefits & Prescription Drugs

Medicare/Medicaid

Medicaid Community Engagement Requirements

District of Columbia

PrEP DC Act of 2025 (DC Council Bill 26-0159)

Budget/Appropriations

CDC domestic HIV and hepatitis prevention, Ryan White HIV/AIDS Program, Ending the HIV Epidemic Initiative, including PrEP activities for community health centers, Minority AIDS Initiative, and NIH AIDS research

Health Issues

Ending the HIV Epidemic initiative, PrEP coverage, CDC HIV Prevention Programs, Ryan White HIV/AIDS Program, Community Health Centers PrEP Program, PrEP Access and Coverage Act of 2026 (S 3990,HR 7853)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.